Parexel, International

Glendale, California 91206

0 studies enrolling now · 18 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Corneal Neovascularization, Healthy, Healthy Participants, Healthy Volunteers, Idiopathic Pulmonary Fibrosis, Migraine, Pharmacokinetics of Isavuconazole, Pharmacokinetics of Lopinavir/Ritonavir, Safety and Tolerability in Elderly, Schizophrenia

Studies at this site

• A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment — Completed
• A Study of E2086 in Healthy Adult Participants — Completed
• Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease — Completed
• A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects — Completed
• Phase1a, Dose-escalation Study of NNI-362 in Healthy Aged Volunteers — Completed
• A Study Investigating the Movement of Lu AG09222 Into, Through, and Out of the Body of Healthy Caucasian, Chinese, and Japanese Participants — Completed
• A Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pelacarsen (ISIS 681257) in Healthy Japanese Participants — Completed
• Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment — Status unconfirmed
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Healthy Participants — Completed
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Oral Dose of TAK-418 in Healthy Female Participants — Stopped early
• A Phase I Study of SB26 in Healthy Volunteers — Completed
• A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Oral Single Dose of TAK-418 in Healthy Participants — Completed
• PK and Safety Study of AG-221 in Healthy Male Japanese Subjects and Healthy Male Caucasian Subjects — Completed
• Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742 in Healthy Adult Subjects — Completed
• Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD — Completed
• Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects — Completed
• Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole — Completed
• Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia — Completed